Althea Group Holdings Ltd. (AU:AGH) has released an update.
Althea Group Holdings Ltd. reported a robust 21% revenue increase to $30.36 million in FY24 and anticipates further growth and profitability in FY25, backed by strategic cost-saving measures and expansion initiatives in the pharmaceutical and recreational cannabis sectors. The company’s pharmaceutical arm, Althea, and its recreational subsidiary, Peak Processing Solutions, showed strong market performances, particularly in the UK and Australia. Despite a non-cash impairment for Peak Canada, AGH is well-positioned for the upcoming year with a focus on the US market and additional cost savings.
For further insights into AU:AGH stock, check out TipRanks’ Stock Analysis page.
